TW200613274A - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- TW200613274A TW200613274A TW094123146A TW94123146A TW200613274A TW 200613274 A TW200613274 A TW 200613274A TW 094123146 A TW094123146 A TW 094123146A TW 94123146 A TW94123146 A TW 94123146A TW 200613274 A TW200613274 A TW 200613274A
- Authority
- TW
- Taiwan
- Prior art keywords
- organic compounds
- compounds
- medicines
- preparation
- general formula
- Prior art date
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003053 piperidines Chemical class 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH11582004 | 2004-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200613274A true TW200613274A (en) | 2006-05-01 |
Family
ID=35448323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094123146A TW200613274A (en) | 2004-07-09 | 2005-07-08 | Organic compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080076766A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1776359B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4842262B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101014594A (cg-RX-API-DMAC7.html) |
| AR (1) | AR053406A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE521607T1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0513199A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2570920A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2372502T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL180242A0 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1776359T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1776359E (cg-RX-API-DMAC7.html) |
| TW (1) | TW200613274A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006005741A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE462703T1 (de) | 2004-08-25 | 2010-04-15 | Actelion Pharmaceuticals Ltd | Bicyclononen-derivate als renin-inhibitoren |
| GB0428526D0 (en) | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
| EP1707202A1 (de) * | 2005-03-31 | 2006-10-04 | Speedel Experimenta AG | Organische Verbindungen |
| WO2006103275A1 (en) * | 2005-03-31 | 2006-10-05 | Speedel Experimenta Ag | 3,4,5-substituted piperidines as renin inhibitors |
| TW200722424A (en) | 2005-03-31 | 2007-06-16 | Speedel Experimenta Ag | Substituted piperidines |
| GB0508992D0 (en) * | 2005-05-03 | 2005-06-08 | Novartis Ag | Organic compounds |
| GB0510810D0 (en) * | 2005-05-26 | 2005-06-29 | Novartis Ag | Organic compounds |
| JP4297972B2 (ja) | 2005-05-27 | 2009-07-15 | アクテリオン ファーマシューティカルズ リミテッド | 新規なピペリジンカルボン酸アミド誘導体 |
| GB0514203D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
| AR058885A1 (es) | 2005-12-30 | 2008-02-27 | Novartis Ag | Compuestos de piperidina 3,5-sustituidos |
| TW200804359A (en) * | 2006-01-19 | 2008-01-16 | Speedel Experimenta Ag | Substituted 4-phenylpiperidines |
| EP1816122A3 (en) * | 2006-01-19 | 2007-09-19 | Speedel Experimenta AG | 3,4,5-substituted piperidines as therapeutic compounds |
| TW200821303A (en) * | 2006-08-08 | 2008-05-16 | Speedel Experimenta Ag | Organic compounds |
| EP1911758A1 (en) * | 2006-10-04 | 2008-04-16 | Speedel Experimenta AG | Phenyl piperidine derivatives for use as renin inhibitors |
| EP1908761A1 (en) * | 2006-10-04 | 2008-04-09 | Speedel Experimenta AG | Organic compounds |
| WO2008074450A2 (en) * | 2006-12-20 | 2008-06-26 | Nicox S.A. | Non-peptidic renin inhibitors nitroderivatives |
| TWI452044B (zh) | 2007-06-15 | 2014-09-11 | Mitsubishi Tanabe Pharma Corp | 嗎啉衍生物 |
| ES2541107T3 (es) | 2007-06-25 | 2015-07-16 | Novartis Ag | Derivados de N5-(2-etoxietil)-N3-(2-piridinil)-3,5-piperidindicarboxamida para su uso como inhibidores de renina |
| AR069005A1 (es) * | 2007-10-25 | 2009-12-23 | Speedel Experimenta Ag | Piperidinas 4,4-disustituidas |
| TW200932241A (en) | 2007-12-05 | 2009-08-01 | Speedel Experimenta Ag | Organic compounds |
| BRPI0907933A2 (pt) | 2008-02-08 | 2015-07-28 | Novartis Ag | Pepiridinas substituídas como inibidoras da renina |
| WO2009098275A1 (en) * | 2008-02-08 | 2009-08-13 | Novartis Ag | Substituted piperidines as renin inhibitors |
| WO2009106599A2 (en) * | 2008-02-29 | 2009-09-03 | Novartis Ag | Substituted piperidines as therapeutic compounds |
| WO2009127251A1 (en) * | 2008-04-16 | 2009-10-22 | Novartis Ag | Combinations comprising a renin inhibitor |
| PL2274295T3 (pl) * | 2008-05-05 | 2016-01-29 | Idorsia Pharmaceuticals Ltd | 3,4–podstawione pochodne piperydyny jako inhibitory reniny |
| AR072166A1 (es) | 2008-06-19 | 2010-08-11 | Takeda Pharmaceutical | Derivado de piperidina y su uso como inhibidor de renina superior |
| EP2163245A1 (en) | 2008-09-10 | 2010-03-17 | Novartis Ag | Renin inhibitors for the treatment of psoriasis |
| WO2010032856A1 (ja) | 2008-09-19 | 2010-03-25 | 武田薬品工業株式会社 | 含窒素複素環化合物およびその用途 |
| WO2010114978A1 (en) * | 2009-04-03 | 2010-10-07 | Merck Sharp & Dohme Corp. | Renin inhibitors |
| US8563035B2 (en) | 2010-05-05 | 2013-10-22 | Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi | Oral tablet compositions of dexlansoprazole |
| EP2384745A3 (en) * | 2010-05-05 | 2012-01-18 | Sanovel Ilac Sanayi ve Ticaret A.S. | Modified release pharmaceutical compositions of dexlansoprazole |
| EP2384746A3 (en) | 2010-05-05 | 2012-03-07 | Sanovel Ilac Sanayi ve Ticaret A.S. | Dual release oral tablet compositions of dexlansoprazole |
| EP4255909A1 (en) * | 2020-12-02 | 2023-10-11 | Qurient Co. Ltd. | Compounds having cyclin-dependent kinase(cdk)-inhibitory function |
| US20250214980A1 (en) | 2022-03-14 | 2025-07-03 | Slap Pharmaceuticals Llc | Multicyclic compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2167865C2 (ru) * | 1995-09-07 | 2001-05-27 | Ф. Хоффманн-Ля Рош Аг | Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества |
| US6197959B1 (en) * | 1999-04-27 | 2001-03-06 | Hoffmann-La Roche Inc. | Piperidine derivatives |
| US6376672B1 (en) * | 1999-04-27 | 2002-04-23 | Hoffmann-La Roche Inc. | Naphthalenylmethoxypiperidines as renin inhibitors |
| JP2004534017A (ja) * | 2001-04-27 | 2004-11-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｂａｃｅのインヒビター |
| US20040204455A1 (en) * | 2003-04-10 | 2004-10-14 | Cody Wayne Livingston | Piperidine derivative rennin inhibitors |
-
2005
- 2005-07-08 TW TW094123146A patent/TW200613274A/zh unknown
- 2005-07-08 AR ARP050102851A patent/AR053406A1/es not_active Application Discontinuation
- 2005-07-11 US US11/631,777 patent/US20080076766A1/en not_active Abandoned
- 2005-07-11 CA CA002570920A patent/CA2570920A1/en not_active Abandoned
- 2005-07-11 WO PCT/EP2005/053306 patent/WO2006005741A2/en not_active Ceased
- 2005-07-11 BR BRPI0513199-5A patent/BRPI0513199A/pt not_active IP Right Cessation
- 2005-07-11 JP JP2007519812A patent/JP4842262B2/ja not_active Expired - Fee Related
- 2005-07-11 AT AT05761185T patent/ATE521607T1/de active
- 2005-07-11 ES ES05761185T patent/ES2372502T3/es not_active Expired - Lifetime
- 2005-07-11 PL PL05761185T patent/PL1776359T3/pl unknown
- 2005-07-11 CN CNA2005800227495A patent/CN101014594A/zh active Pending
- 2005-07-11 PT PT05761185T patent/PT1776359E/pt unknown
- 2005-07-11 EP EP05761185A patent/EP1776359B1/en not_active Expired - Lifetime
-
2006
- 2006-12-21 IL IL180242A patent/IL180242A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL180242A0 (en) | 2007-07-04 |
| ATE521607T1 (de) | 2011-09-15 |
| CN101014594A (zh) | 2007-08-08 |
| US20080076766A1 (en) | 2008-03-27 |
| WO2006005741A3 (en) | 2006-07-06 |
| EP1776359B1 (en) | 2011-08-24 |
| CA2570920A1 (en) | 2006-01-19 |
| EP1776359A2 (en) | 2007-04-25 |
| JP4842262B2 (ja) | 2011-12-21 |
| PT1776359E (pt) | 2011-12-15 |
| JP2008505871A (ja) | 2008-02-28 |
| HK1104037A1 (en) | 2008-01-04 |
| AR053406A1 (es) | 2007-05-09 |
| WO2006005741A2 (en) | 2006-01-19 |
| PL1776359T3 (pl) | 2012-01-31 |
| ES2372502T3 (es) | 2012-01-20 |
| BRPI0513199A (pt) | 2008-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200613274A (en) | Organic compounds | |
| TW200611898A (en) | Organic compounds | |
| TW200616623A (en) | Organic compounds | |
| TW200608978A (en) | Organic compounds | |
| TW200716636A (en) | Heterocyclic spiro-compounds | |
| CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
| TW200505920A (en) | Organic compounds | |
| TW200611897A (en) | Organic compounds | |
| TW200716634A (en) | Heterocyclic spiro-compounds | |
| TW200716105A (en) | Imidazole compounds | |
| TW200732335A (en) | Organic compounds | |
| SE0401762D0 (sv) | Novel compounds | |
| DE602004024213D1 (en) | Aminopropanolderivate | |
| TW200609215A (en) | Organic compounds | |
| GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
| SE0400850D0 (sv) | Novel Compounds | |
| IL174469A0 (en) | Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics | |
| MXPA05013823A (es) | Derivados de pirrolidinio y piperidino como ligandos para el receptor m3 muscarinico. | |
| TW200732325A (en) | Organic compounds | |
| GB0411929D0 (en) | Organic compounds | |
| BRPI0519292A2 (pt) | compostos orgÂnicos | |
| TW200702330A (en) | 3,4,5-Substituted piperidines | |
| TW200732337A (en) | Organic compounds | |
| SE0403085D0 (sv) | Novel componds | |
| GB0428416D0 (en) | Organic compounds |